TELUS investment part of Teradici’s new US $17 million funding round
Burnaby, British Columbia April 7, 2009 – Teradici Corporation, the industry leader in delivering a true PC experience over standard IP networks, today announced completion of a US $17 million series C funding round for its PC-over-IP network-delivered computing technology. With network-delivered computing, users can work at inexpensive computer stations at any site, with all operating systems, applications, and data residing in central datacenters.
VANCOUVER, BC, April 6, 2009 – Ondine Biopharma Corporation (the “Company” or “Ondine”, TSX: OBP; AIM: OBP) a medical technology company developing photodisinfection based products, today announced that it has entered into a loan agreement with Carolyn Cross, Chairman, CEO and a shareholder of the Company, pursuant to which Ms. Cross has advanced the Company C$400,000 (the “Loan”), demonstrating continued support of the Company. Ms.
CON-SPACE Communications Ltd. (the “Company” or “CON-SPACE”) (TSX-V: CCB), today announced that it is proceeding with a private placement of 22,000,000 common shares at $0.05 each, for gross proceeds of $1,100,000, to Turret Oy Ab (“Turret”), its largest shareholder and secured lender. Completion of the private placement is subject to regulatory approval and is subject to completion of a proposed restructuring to address the Company’s current serious financial difficulties.
VANCOUVER, April 1 - Lignol Energy Corporation (TSX-V: LEC) ("Lignol" or "the Company"), a leading technology company in the cellulosic ethanol and biorefining sector, today announced that it has completed the second and final tranche of the non-brokered private placement that was previously announced on February 12, 2009. Under this second tranche, the Company issued 2,047,885 common shares for gross proceeds of $839,632.85.
Proceeds Will Advance Key New Products Including Completing CE Mark Application for the Reducer™ Stent
Vancouver, B.C. – March 19, 2009 – Lignol Energy Corporation (TSX-V: LEC) (“Lignol” or “the Company”), a leading technology company in the cellulosic ethanol and biorefining sector, today announced that a project led by its wholly-owned subsidiary, Lignol Innovations Ltd., has been awarded up to $1.82 million in additional funding contributions from Sustainable Development Technology Canada (SDTC).
Company Will Use New Funding for Global Expansion of Sales and Marketing, Continued R&D
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced it has obtained a new Senior Secured Term Loan and Revolving Credit Facility. Wells Fargo Foothill, LLC is the sole arranger, administrative agent and lender for both the Term Loan and Revolving Credit Facility.
Victoria, British Columbia - February 25, 2009 - GenoLogics has completed $5 million in financing, which will be applied towards ongoing expansion plans.
The latest round of financing was led by OVP Venture Partners of Seattle with support from Growth Works and Yaletown Venture Partners of Vancouver. The funds will be used to accelerate development and global deployment of an end-to-end informatics solution for organizations pursuing translational research initiatives.
Vancouver, Canada – February 23, 2009 - Ondine Biopharma Corporation (TSX: OBP; AIM: OBP) (the “Company”) a medical technology company developing photodisinfection based products, today announced it has closed the second tranche of its previously announced non-brokered private placement by issuing 1,650,168 common shares at a price of $0.06 per share for aggregate gross proceeds of C$99,010 to qualified investors pursuant to applicable exemptions.